While an agency analysis did find signs of Covid “rebound,” the drug significantly reduces hospitalizations and deaths, researchers said.
This post first appeared in The New York Times – Business. Read the original article.F.D.A. Advisers Endorse Paxlovid’s Benefits as a Covid Treatment
The New York Times – Business:
Written by
in
